Search Results - "Elena V. Esaulenko"
-
1
CX3CL1/Fractalkine: A Potential Biomarker for Liver Fibrosis in Chronic HBV Infection
Published in Current issues in molecular biology (10-09-2024)“…A hepatitis B virus (HBV) infection can progress to chronic hepatitis, leading to liver fibrosis, cirrhosis, and hepatocellular carcinoma. CX3CL1/Fractalkine…”
Get full text
Journal Article -
2
A new approach to etiotropic therapy ARVI in children
Published in Terapevtic̆eskii arhiv (26-12-2022)“…Confirmation of the efficacy and safety of the drug riamilovir (Triazavirin ), 100 mg capsules, in children aged 12-17 years with the diagnosis of acute viral…”
Get full text
Journal Article -
3
Prevalence of HIV and Viral Hepatitis Markers among Healthcare Workers in the Republic of Guinea
Published in Diagnostics (Basel) (19-01-2023)“…Healthcare workers are much more likely to be infected with HIV and hepatitis viruses compared to the general population. Although healthcare workers are more…”
Get full text
Journal Article -
4
Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation
Published in Clinical infectious diseases (02-11-2021)“…Abstract Background This study compares the immunogenicity and safety of a 3-antigen (S/pre-S1/pre-S2) hepatitis B (HepB) vaccine (3AV), to a single antigen…”
Get full text
Journal Article -
5
Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19
Published in Terapevtic̆eskii arhiv (16-04-2024)“…Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with…”
Get full text
Journal Article -
6
Hepatitis B virus preCore/Core region variability in pregnant women in the Republic of Guinea
Published in Žurnal mikrobiologii, ėpidemiologii i immunobiologii (13-03-2024)“…Introduction. The vertical route of hepatitis B virus (HBV) transmission is a significant problem in African countries, which is characterized by late…”
Get full text
Journal Article -
7
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial
Published in Terapevtic̆eskii arhiv (23-11-2023)“…To evaluate the efficacy and safety of OM-85 in the treatment of uncomplicated acute respiratory infections (ARI) in adults. A double-blind,…”
Get full text
Journal Article -
8
Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis
Published in Infekt͡s︡ii͡a︡ i immunitet (15-11-2022)“…Pathological conditions of various natures are capable of mutual aggravation, significantly affecting the overall burden of the disease, its manifestations and…”
Get full text
Journal Article -
9
Frequency of drug resistance and immune escape mutations in the hepatitis B virus genome detected in pregnant women in the Republic of Guinea
Published in Voprosy virusologiĭ (06-07-2023)“…The aim of the work is to assess the prevalence of hepatitis B virus drug resistance mutations and immune escape mutations in pregnant women in the Republic of…”
Get full text
Journal Article -
10
Association between Higher CD32a+CD4+ T Cell Count and Viral Load in the Peripheral Blood of HIV-infected Patients
Published in The open AIDS journal (13-07-2021)“…Background: The significance of CD32a receptor expression in individuals infected with Human Immunodeficiency Virus (HIV) is currently unclear. Previously, B…”
Get full text
Journal Article -
11
Birch bark extract as therapy for chronic hepatitis C – A pilot study
Published in Phytomedicine (Stuttgart) (15-07-2011)“…The hepatoprotective effect of birch bark extract (BBE) in patients with chronic hepatitis C (CHC) was studied. Forty-two patients with serologically confirmed…”
Get full text
Journal Article -
12
Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19
Published in Terapevtic̆eskii arhiv (03-06-2024)“…To evaluate the efficacy and safety of riamilovir in the treatment of COVID-19 in adults. The study included 180 patients with a laboratory-confirmed diagnosis…”
Get full text
Journal Article -
13
Сlinical and immunological status of patients with chronic hepatitis С on the background of comorbidity
Published in Consilium medicum (Online) (2021)“…Aim. To study the clinical and immunological features of the course of chronic hepatitis C (CHC) in patients with an unfavorable comorbid background. Materials…”
Get full text
Journal Article -
14
CYTOKINES, CHEMOKINES AND GROWTH FACTORS ASSOCIATED WITH CHRONIC VIRAL HEPATITIS C
Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-08-2019)“…Chronic hepatitis C (CHC) represents a significant public health concern. In the majority of cases, the infection progresses to a chronic form, which is…”
Get full text
Journal Article -
15
Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea
Published in Voprosy virusologiĭ (15-03-2022)“…Introduction. The problem of transfusion safety in relation to parenteral viral hepatitis still remains relevant. Viral hepatitis B (HB) remains the most…”
Get full text
Journal Article -
16
Infective endocarditis in a series of 1527 autopsies: clinical-pathology correlations
Published in Le infezioni in medicina (01-12-2002)“…The study of 1527 autopsies showed that in 2% of cases the cause of death was Infective Endocarditis (IE) (acute in the absolute majority), mostly not…”
Get full text
Journal Article -
17
Infective endocarditis in a series of 1527 autopsies: clinical-pathology correlations
Published in Le infezioni in medicina (01-12-2002)Get full text
Journal Article